GR3026554T3 - Human CNP gene and precursor protein - Google Patents

Human CNP gene and precursor protein

Info

Publication number
GR3026554T3
GR3026554T3 GR980400741T GR980400741T GR3026554T3 GR 3026554 T3 GR3026554 T3 GR 3026554T3 GR 980400741 T GR980400741 T GR 980400741T GR 980400741 T GR980400741 T GR 980400741T GR 3026554 T3 GR3026554 T3 GR 3026554T3
Authority
GR
Greece
Prior art keywords
precursor protein
human cnp
human
cnp gene
gene
Prior art date
Application number
GR980400741T
Other languages
English (en)
Inventor
Shoji Tanaka
Kayoko Fuchimura
Yasunori Tawaragi
Hisayuki Matsuo
Kenji Kangawa
Naoto Minamino
Original Assignee
Suntory Ltd
Hisayuki Matsuo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd, Hisayuki Matsuo filed Critical Suntory Ltd
Publication of GR3026554T3 publication Critical patent/GR3026554T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
GR980400741T 1990-09-27 1998-04-06 Human CNP gene and precursor protein GR3026554T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP02259698A JP3026354B2 (ja) 1990-09-27 1990-09-27 ヒトｃｎｐ遺伝子及び前駆体蛋白

Publications (1)

Publication Number Publication Date
GR3026554T3 true GR3026554T3 (en) 1998-07-31

Family

ID=17337688

Family Applications (1)

Application Number Title Priority Date Filing Date
GR980400741T GR3026554T3 (en) 1990-09-27 1998-04-06 Human CNP gene and precursor protein

Country Status (8)

Country Link
US (1) US6034231A (el)
EP (2) EP0769554B1 (el)
JP (1) JP3026354B2 (el)
AT (2) ATE388165T1 (el)
DE (2) DE69133593T2 (el)
DK (1) DK0477971T3 (el)
ES (2) ES2302333T3 (el)
GR (1) GR3026554T3 (el)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL142118A0 (en) * 2001-03-20 2002-03-10 Prochon Biotech Ltd Method and composition for treatment of skeletal dysplasias
BRPI0203172B8 (pt) 2001-09-28 2021-05-25 Nakao Kazuwa composição farmacêutica para acondroplasia
AU2003297583B2 (en) 2002-11-26 2010-01-14 Biocon, Ltd Modified naturetic compounds, conjugates, and uses thereof
ES2465141T3 (es) * 2004-03-31 2014-06-05 Kazuwa Nakao Remedio o medicamento preventivo para la artritis
EP3446711A1 (en) 2004-03-31 2019-02-27 Kazuwa Nakao Composition for increasing body height
PL3404102T3 (pl) 2004-04-21 2021-12-13 Alexion Pharmaceuticals, Inc. Koniugaty do dostarczania do kości i sposób ich wykorzystania do nakierowywania białek na kość
US20080207505A1 (en) * 2005-01-12 2008-08-28 James Kenneth D Bna Conjugates and Methods of Use
US20070184466A1 (en) * 2005-11-18 2007-08-09 The Brigham And Women's Hospital, Inc. Detection, generation and uses of atherosclerosis-protective endothelium
AU2008326327A1 (en) * 2007-11-21 2009-05-28 Biomarin Pharmaceutical Inc. Variants of C-type natriuretic peptide
JP5524049B2 (ja) * 2008-05-23 2014-06-18 第一三共株式会社 目的ペプチドの血漿中半減期延長作用を有するペプチド
MX2011012277A (es) * 2009-05-20 2011-12-12 Biomarin Pharm Inc Variantes de peptidos natriureticos de tipo c.
CA2823066A1 (en) 2010-12-27 2012-07-05 Alexion Pharma International Sarl Compositions comprising natriuretic peptides and methods of use thereof
CA2852874A1 (en) 2011-10-19 2013-04-25 Alexion Pharma Holding Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof
US10052366B2 (en) 2012-05-21 2018-08-21 Alexion Pharmaceuticsl, Inc. Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof
US10822596B2 (en) 2014-07-11 2020-11-03 Alexion Pharmaceuticals, Inc. Compositions and methods for treating craniosynostosis
RU2708068C2 (ru) 2014-12-05 2019-12-04 Алексион Фармасьютикалз, Инк. Лечение судорог с использованием рекомбинантной щелочной фосфатазы
JP6868561B2 (ja) 2015-01-28 2021-05-12 アレクシオン ファーマシューティカルズ， インコーポレイテッド アルカリホスファターゼ欠損を有する被験者を治療する方法
KR20180030414A (ko) 2015-07-30 2018-03-22 바이오마린 파머수티컬 인크. 골 이형성증 치료를 위한 c―형 나트륨이뇨 펩타이드 변이체의 용도
CN108350440A (zh) 2015-08-17 2018-07-31 阿雷克森制药公司 碱性磷酸酯的制造
EP3355904A4 (en) 2015-09-28 2019-06-12 Alexion Pharmaceuticals, Inc. IDENTIFICATION OF EFFECTIVE DOSE SHEETS FOR TISSUE-SPECIFIC ALKALINE PHOSPHATASE ENZYMERSAT THERAPY OF HYPOPHOSPHATASIA
WO2017074466A1 (en) 2015-10-30 2017-05-04 Alexion Pharmaceuticals, Inc. Methods for treating craniosynostosis in a patient
US11065306B2 (en) 2016-03-08 2021-07-20 Alexion Pharmaceuticals, Inc. Methods for treating hypophosphatasia in children
US10898549B2 (en) 2016-04-01 2021-01-26 Alexion Pharmaceuticals, Inc. Methods for treating hypophosphatasia in adolescents and adults
EP3436052A4 (en) 2016-04-01 2019-10-09 Alexion Pharmaceuticals, Inc. TREATMENT OF MUSCLE WEAKNESS USING ALKALINE PHOSPHATASES
WO2017214130A1 (en) 2016-06-06 2017-12-14 Alexion Pharmaceuticals, Inc. Metal impact on manufacturing of alkaline phosphatases
JP7018933B2 (ja) 2016-08-18 2022-02-14 アレクシオン ファーマシューティカルズ， インコーポレイテッド 気管気管支軟化症の治療方法
US11224637B2 (en) 2017-03-31 2022-01-18 Alexion Pharmaceuticals, Inc. Methods for treating hypophosphatasia (HPP) in adults and adolescents
WO2019190752A1 (en) 2018-03-30 2019-10-03 Alexion Pharmaceuticals, Inc. Manufacturing of glycoproteins
MX2022003184A (es) 2019-09-16 2022-06-23 Biomarin Pharm Inc Variantes del cnp y sus conjugados.
WO2023283657A1 (en) 2021-07-09 2023-01-12 Biomarin Pharmaceutical Inc. C-type natriuretic peptide variants to treat skeletal dysplasia in children
WO2023108005A1 (en) 2021-12-07 2023-06-15 Biomarin Pharmaceutical Inc. C-type natriuretic peptide therapy of bone-related disorders

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1339210C (en) * 1988-05-31 1997-08-05 John Lewicki Recombinant techniques for production of novel natriuretic and vasodilator peptides

Also Published As

Publication number Publication date
DE69128754T2 (de) 1998-06-04
JP3026354B2 (ja) 2000-03-27
EP0769554A2 (en) 1997-04-23
JPH04139199A (ja) 1992-05-13
EP0477971A3 (en) 1992-09-09
US6034231A (en) 2000-03-07
DK0477971T3 (da) 1998-09-21
ES2302333T3 (es) 2008-07-01
ES2113865T3 (es) 1998-05-16
DE69133593D1 (de) 2008-04-17
EP0477971B1 (en) 1998-01-21
ATE162532T1 (de) 1998-02-15
DE69133593T2 (de) 2009-04-02
DE69128754D1 (de) 1998-02-26
EP0477971A2 (en) 1992-04-01
EP0769554B1 (en) 2008-03-05
EP0769554A3 (en) 1997-05-28
ATE388165T1 (de) 2008-03-15

Similar Documents

Publication Publication Date Title
GR3026554T3 (en) Human CNP gene and precursor protein
AU2964489A (en) Dna sequences, recombinant dna molecules and processes for producing human immune interferon-like polypeptides
AU7165287A (en) DNA encoding streptavidin, streptavidin produced therefrom, fused polypeptides which include amino acid sequences present in streptavidin and uses thereof
EP0347435A4 (en) Dna sequences, recombinant dna molecules and processes for producing soluble t4 proteins
IL131016A0 (en) Selection of proteins using rna-protein fusions
ZA81103B (en) Dna sequences ,recombinant dna molecules dna molecules and processes for producing human interferon -like polypeptides
CY1346A (en) Dna sequences,recombinant dna molecules and processes for producing human interferon-like polypeptides
HUT77049A (hu) Katepszin-02-fehérjék, -nukleinsavak és -ellenanyagok
HUT46061A (en) Dna sequences encoding hirudin-like protein and process for producing such proteins
AU631681B2 (en) Radiolabeled anticoagulant peptides
HU9203753D0 (en) Protein having cytoqinic-like effect recombinant dna sequence coding it corresponding transformed cells and micro-organisms
ZA86217B (en) Dna sequences,recombinant dna molecules and processes for producing human lipocortin-like polypeptides
AU4971385A (en) A process for the cleavage of peptides and proteins at the methionyl bond
HK187896A (en) Genetic sequences type I interferon peptide coded by them and these organisms producing the same
HUT46359A (en) Dna molecules encoding deacetoxy-cefalosporin-c-synthetase and deacetyl-cefalosporin-c-synthetase and recombinant dna vectors
GB8702171D0 (en) Protein hydrolysates
EP0669930A4 (en) CELLULAR GENES ENCODING PROTEINS ASSOCIATED WITH RETINOBLASTOMA.
AU8957091A (en) Immunoglobulin-binding proteins and recombinant dna molecules coding therefor
EP0723016A3 (en) Leukocyte activation factor
IL111582A0 (en) Gene encoding cationic amino acid transporter protein
EP0267272A4 (en) ATRIAL NATURAL PEPTIDE RECEPTOR PROTEIN AND ITS DNA CODING.
PT966533E (pt) Factor neurotrófico iii dependente da actividade (adnf iii)
IE882662L (en) Dna sequences, recombinant dna molecules for producing¹soluble t4 proteins
ZA886593B (en) Dna sequences,recombinant dna molecules and processes for producing soluble t4 proteins
ATE75255T1 (de) Peptid und dafuer kodierendes gen.